AllSight
Companies · TNDM · Surgical & Medical Instruments & Apparatus

TANDEM DIABETES CARE INC (TNDM)

TANDEM DIABETES CARE INC (TNDM) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

TANDEM DIABETES CARE INC (TNDM) stock — financials & valuation

Key numbers for TANDEM DIABETES CARE INC (TNDM): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 42/100 — a percentile rank of TANDEM DIABETES CARE INC’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$1.1B
P / S1.1×
EV / EBITDA-60.2×
Gross margin56.0%
Operating margin-4.4%
Net margin-6.1%
Return on equity-48.6%
ROIC-7.1%
Revenue growth4.0%
Debt / equity4.6×
Dividend yield0.0%

Is TANDEM DIABETES CARE INC overvalued? P/S looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.

Independent of the events above — derived from TANDEM DIABETES CARE INC’s own financial statements and shown as context, never as advice.

Aug 6, 2026
Revenue missed consensus, but margins and EPS improved meaningfully.
Related companies in Surgical & Medical Instruments & Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact